VTGN

3.55

1.93% -0.07

Dopo l'orario di chiusura: 3.55

Vistagen Therapeutics Inc (VTGN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$3.62

Aprire:

$3.63

Volume 24 ore:

273.21K

Relative Volume:

0.66

Capitalizzazione di mercato:

$108.92M

Reddito:

$875.70K

Utile/perdita netta:

$-39.57M

Rapporto P/E:

-2.6447

EPS:

-1.3423

Flusso di cassa netto:

$-33.65M

1 W Prestazione:

+6.29%

1M Prestazione:

+21.58%

6M Prestazione:

+31.48%

1 anno Prestazione:

+8.90%

Intervallo 1D:

$3.52

$3.6965

Intervallo di 1 settimana:

$3.34

$3.88

Portata 52W:

$1.90

$3.88

Vistagen Therapeutics Inc Stock (VTGN) Company Profile

Nome

Vistagen Therapeutics Inc

Settore

Healthcare (1149)

Industria

Biotechnology (644)

Telefono

650-577-3600

Indirizzo

343 ALLERTON AVENUE, SOUTH SAN FRANCISCO

Dipendente

Cinguettio

@vistagen

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

VTGN's Discussions on Twitter

Confronta VTGN con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
VTGN Vistagen Therapeutics Inc	3.55	111.06M	875.70K	-39.57M	-33.65M	-1.3423
VRTX Vertex Pharmaceuticals Inc	396.12	101.77B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	573.38	60.12B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	452.00	59.45B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	750.78	44.90B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	341.80	35.07B	3.81B	-644.79M	-669.77M	-6.24

Vistagen Therapeutics Inc Stock (VTGN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-12-07	Aggiornamento	Jefferies	Hold → Buy
2023-08-07	Aggiornamento	Maxim Group	Hold → Buy
2022-07-22	Downgrade	Jefferies	Buy → Hold
2022-07-22	Downgrade	Robert W. Baird	Outperform → Neutral
2022-07-22	Downgrade	William Blair	Outperform → Mkt Perform
2021-05-20	Iniziato	Robert W. Baird	Outperform
2021-02-18	Iniziato	Jefferies	Buy
2021-01-04	Aggiornamento	William Blair	Mkt Perform → Outperform
2018-06-27	Iniziato	Maxim Group	Buy
2018-02-08	Reiterato	Chardan Capital Markets	Buy
2017-03-28	Iniziato	Maxim Group	Buy

Mostra tutto

Vistagen Therapeutics Inc Borsa (VTGN) Ultime notizie

08:54 AM

ADAR1 Capital Management LLC Buys 299,304 Shares of VistaGen Therapeutics, Inc. $VTGN - MarketBeat

08:54 AM

05:13 AM

Can Vistagen Therapeutics Inc. rally from current levelsWeekly Profit Report & Proven Capital Preservation Methods - Newser

05:13 AM

Sep 05, 2025

Using AI based signals to follow Vistagen Therapeutics Inc.2025 Fundamental Recap & Weekly High Momentum Picks - Newser

Sep 05, 2025

Price momentum metrics for Vistagen Therapeutics Inc. explainedPortfolio Growth Summary & Weekly Chart Analysis and Trade Guides - Newser

Sep 05, 2025

Real time social sentiment graph for Vistagen Therapeutics Inc.July 2025 News Drivers & Technical Analysis for Trade Confirmation - Newser

Sep 05, 2025

Is Vistagen Therapeutics Inc. stock undervalued right nowJuly 2025 Short Interest & Growth Oriented Trading Recommendations - خودرو بانک

Sep 05, 2025

Sep 04, 2025

Is this a good reentry point in Vistagen Therapeutics Inc.Portfolio Performance Report & AI Enhanced Trade Execution Alerts - Newser

Sep 04, 2025

How to build a custom watchlist for Vistagen Therapeutics Inc.July 2025 Retail & Risk Adjusted Swing Trade Ideas - Newser

Sep 04, 2025

Vistagen Therapeutics Inc. stock retracement – recovery analysis2025 Key Highlights & Weekly High Return Stock Opportunities - Newser

Sep 04, 2025

Earnings visualization tools for Vistagen Therapeutics Inc.Stop Loss & Fast Gain Stock Trading Tips - Newser

Sep 04, 2025

How to monitor Vistagen Therapeutics Inc. with trend dashboardsMarket Growth Review & Growth-Oriented Investment Plans - Newser

Sep 04, 2025

Can trapped investors hope for a rebound in Vistagen Therapeutics Inc.July 2025 Movers & Expert Approved Momentum Ideas - Newser

Sep 04, 2025

Sep 03, 2025

Technical analysis overview for Vistagen Therapeutics Inc. stockEarnings Risk Report & AI Enhanced Trading Alerts - Newser

Sep 03, 2025

Vistagen Therapeutics Inc. stock outlook for YEARJuly 2025 PreEarnings & Growth-Oriented Investment Plans - Newser

Sep 03, 2025

Measuring Vistagen Therapeutics Inc.’s beta against major indicesWeekly Investment Recap & Free AI Powered Buy and Sell Recommendations - Newser

Sep 03, 2025

Is Vistagen Therapeutics Inc. forming a bullish divergenceJobs Report & Capital Efficient Trade Techniques - khodrobank.com

Sep 03, 2025

Tick level data insight on Vistagen Therapeutics Inc. volatilityCEO Change & Free High Return Stock Watch Alerts - Newser

Sep 03, 2025

Vistagen Therapeutics Inc. stock chart pattern explainedIPO Watch & Weekly High Return Stock Opportunities - Newser

Sep 03, 2025

Is Vistagen Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Action & High Accuracy Swing Entry Alerts - Newser

Sep 03, 2025

Why is Vistagen Therapeutics Inc. stock going down2025 Growth vs Value & Accurate Buy Signal Notifications - خودرو بانک

Sep 03, 2025

What to do if you’re stuck in Vistagen Therapeutics Inc.Earnings Growth Summary & Weekly Market Pulse Updates - Newser

Sep 03, 2025

Should you buy the dip on Vistagen Therapeutics Inc.2025 Analyst Calls & Fast Gaining Stock Strategy Reports - خودرو بانک

Sep 03, 2025

Sep 02, 2025

Is Vistagen Therapeutics Inc.’s growth already priced inJuly 2025 Patterns & Low Risk High Win Rate Stock Picks - خودرو بانک

Sep 02, 2025

Using flow based indicators on Vistagen Therapeutics Inc.2025 Support & Resistance & Risk Controlled Swing Alerts - Newser

Sep 02, 2025

VistaGen Bets On Nasal Therapies For Anxiety And Depression - Finimize

Sep 02, 2025

Is Vistagen Therapeutics Inc. a top pick in the sectorJuly 2025 Drop Watch & Smart Investment Allocation Insights - خودرو بانک

Sep 02, 2025

Published on: 2025-09-02 16:30:46 - خودرو بانک

Sep 02, 2025